Epidemiology and Treatment of Beta Thalassemia Major in China

Overview

Journal Pediatr Investig

Specialty Pediatrics

Date 2020 Aug 28

PMID 32851341

Citations 6

Authors

Xiaoxiao Xu

Xuedong Wu

Affiliations

Soon will be listed here.

Abstract

Thalassemia, classified as the main types α- and β-thalassemia, is a single gene disorder resulting from globin chain synthesis impairment through the mutation or deletion of globin genes. The incidence of thalassemia is high worldwide, with high associated mortality. Therefore, treatment is important to improve patient outcomes. This paper reviews the current status of β-thalassemia major in China, including its epidemiology and treatment.

Citing Articles

Transfusion burden and willingness to pay for temporary alleviation of anemia status in transfusion-dependent beta-thalassemia patients in China.

Chen S, Liu Y, Yin X, Lu Q, Du X, Huang R BMC Health Serv Res. 2024; 24(1):1215.

PMID: 39390469 PMC: 11468025. DOI: 10.1186/s12913-024-11547-2.

Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy.

Chappell M, Breda L, Tricoli L, Guerra A, Jarocha D, Castruccio Castracani C Blood. 2024; 144(15):1633-1645.

PMID: 38949981 PMC: 11487647. DOI: 10.1182/blood.2023023349.

Risk of gout attack not increased in patients with thalassemia: a population-based cohort study.

Chen J, Xu Q, Yang P, Huang J, Cheng-Chung Wei J Sci Rep. 2023; 13(1):2756.

PMID: 36797295 PMC: 9935512. DOI: 10.1038/s41598-023-29709-3.

Spatial and Temporal Expression Characteristics of the Gene Family in Six Different Pig Breeds.

Guo X, Liu Z, Mu Y, Huang L, Li K, Zhang J Genes (Basel). 2022; 13(10).

PMID: 36292707 PMC: 9601290. DOI: 10.3390/genes13101822.

Molecular Spectrum, Ethnic and Geographical Distribution of Thalassemia in the Southern Area of Hainan, China.

Yu Y, Lu C, Gao Y, Li C, Li D, Wang J Front Pediatr. 2022; 10:894444.

PMID: 35783323 PMC: 9245522. DOI: 10.3389/fped.2022.894444.

References

Taher A, Musallam K, Inati A . The hypercoagulable state in thalassemia intermedia. Hemoglobin. 2009; 33 Suppl 1:S160-9. DOI: 10.3109/03630260903351619. View

Ramezanzadeh M, Salehi M, Farajzadegan Z, Kamali S, Salehi R . Detection of paternally inherited fetal point mutations for β-thalassemia in maternal plasma using simple fetal DNA enrichment protocol with or without whole genome amplification: an accuracy assessment. J Matern Fetal Neonatal Med. 2015; 29(16):2645-9. DOI: 10.3109/14767058.2015.1095883. View

Jaing T, Hung I, Yang C, Chen S, Chung H, Tsay P . Unrelated cord blood transplantation for thalassaemia: a single-institution experience of 35 patients. Bone Marrow Transplant. 2011; 47(1):33-9. DOI: 10.1038/bmt.2011.39. View

Xu X, Zhou Y, Luo G, Liao C, Zhou M, Chen P . The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004; 57(5):517-22. PMC: 1770296. DOI: 10.1136/jcp.2003.014456. View

Ma Y, Li J, Gao E, Qian D, Zhong J, Liu C . [Progress of gene editing technologies and prospect in traditional Chinese medicine]. Zhongguo Zhong Yao Za Zhi. 2017; 42(1):34-40. DOI: 10.19540/j.cnki.cjcmm.20161222.003. View

Vichinsky E . Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management. Curr Med Res Opin. 2015; 32(1):191-204. DOI: 10.1185/03007995.2015.1110128. View

Liu Y, Yang Y, Kang X, Lin B, Yu Q, Song B . One-Step Biallelic and Scarless Correction of a β-Thalassemia Mutation in Patient-Specific iPSCs without Drug Selection. Mol Ther Nucleic Acids. 2017; 6:57-67. PMC: 5363452. DOI: 10.1016/j.omtn.2016.11.010. View

Sun Q, Wu B, Lan H, Meng F, Ma X, Chen X . Haploidentical haematopoietic stem cell transplantation for thalassaemia major based on an FBCA conditioning regimen. Br J Haematol. 2018; 182(4):554-558. PMC: 6120500. DOI: 10.1111/bjh.15438. View

Xu P, Tong Y, Liu X, Wang T, Cheng L, Wang B . Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs. Sci Rep. 2015; 5:12065. PMC: 4496796. DOI: 10.1038/srep12065. View

10.

Al-Salem A . Splenectomy for Children With Thalassemia: Total or Partial Splenectomy, Open or Laparoscopic Splenectomy. J Pediatr Hematol Oncol. 2014; 38(1):1-4. DOI: 10.1097/MPH.0000000000000121. View

11.

Shahrokhi S, Menaa F, Alimoghaddam K, McGuckin C, Ebtekar M . Insights and hopes in umbilical cord blood stem cell transplantations. J Biomed Biotechnol. 2012; 2012:572821. PMC: 3509718. DOI: 10.1155/2012/572821. View

12.

Cao A . Carrier screening and genetic counselling in beta-thalassemia. Int J Hematol. 2002; 76 Suppl 2:105-13. DOI: 10.1007/BF03165098. View

13.

Hu H, Li C, Xiong Q, Gao H, Li Y, Chang Q . Prenatal diagnosis of beta-thalassemia by chip-based capillary electrophoresis. Prenat Diagn. 2008; 28(3):222-9. DOI: 10.1002/pd.1932. View

14.

Xu X, Wu X . Epidemiology and treatment of beta thalassemia major in China. Pediatr Investig. 2020; 4(1):43-47. PMC: 7331292. DOI: 10.1002/ped4.12154. View

15.

Locatelli F, Kabbara N, Ruggeri A, Ghavamzadeh A, Roberts I, Li C . Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood. 2013; 122(6):1072-8. DOI: 10.1182/blood-2013-03-489112. View

16.

Li C . New trend in the epidemiology of thalassaemia. Best Pract Res Clin Obstet Gynaecol. 2016; 39:16-26. DOI: 10.1016/j.bpobgyn.2016.10.013. View

17.

Angelucci E, Barosi G, Camaschella C, Cappellini M, Cazzola M, Galanello R . Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. Haematologica. 2008; 93(5):741-52. DOI: 10.3324/haematol.12413. View

18.

Borgna-Pignatti C . The life of patients with thalassemia major. Haematologica. 2010; 95(3):345-8. PMC: 2833059. DOI: 10.3324/haematol.2009.017228. View

19.

Mohamed S . Thalassemia Major: Transplantation or Transfusion and Chelation. Hematol Oncol Stem Cell Ther. 2017; 10(4):290-298. DOI: 10.1016/j.hemonc.2017.05.022. View

20.

Choudhry V . Thalassemia Minor and Major: Current Management. Indian J Pediatr. 2017; 84(8):607-611. DOI: 10.1007/s12098-017-2325-1. View